Q2 2025 MANI Inc Earnings Presentation Transcript
Good morning, everyone. Thank you for taking the time of your busy schedules to attend today's presentation. I would like to begin explaining our financial results for the second quarter of fiscal year 2025.
The first issue on today's agenda is the voluntary recall of MANI DIA-BURS in China. On March 14, upon discovering that the product registration information submitted to the Chinese regulatory authorities was incomplete, we made the decision to carry out the voluntary recall of the product lines affected.
The recall is currently underway. Since this issue is related to the application to the Chinese regulatory authorities, we have determined that there will be no impact on patients' health, as well as sales to other regions. We are also
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

